Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|June 26, 2024
High-Throughput Protein Expression Screening of Cell-Surface Protein EctodomainsAnita Ghosh, Chang Yang, Kenneth Lloyd, et al.
Nature Reviews. Drug Discovery|June 2, 2009
Development of pharmacotherapies for drug addiction: a Rosetta stone approachGeorge F Koob, G Kenneth Lloyd, Barbara J Mason
Cancer Chemotherapy and Pharmacology|December 8, 2019
Plinabulin ameliorates neutropenia induced by multiple chemotherapies through a mechanism distinct from G-CSF therapiesJames R Tonra, G Kenneth Lloyd, Ramon Mohanlal, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 18, 2003
Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptorsBruno Bontempi, Kevin T Whelan, Victoria B Risbrough, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
Antibodies against tumor cell glycolipids and proteins, but not mucins, mediate complement-dependent cytotoxicityGovind Ragupathi, Nancy X Liu, Cristina Musselli, et al.
Bioorganic & Medicinal Chemistry|November 22, 2008
Discovery and development of the anticancer agent salinosporamide A (NPI-0052)William Fenical, Paul R Jensen, Michael A Palladino, et al.
British Journal of Haematology|March 25, 2010
Pharmacodynamic and efficacy studies of the novel proteasome inhibitor NPI-0052 (marizomib) in a human plasmacytoma xenograft murine modelAjita V Singh, Michael A Palladino, George Kenneth Lloyd, et al.
Neuro-Oncology|December 19, 2015
Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrierKaijun Di, G Kenneth Lloyd, Vivek Abraham, et al.
Anti-Cancer Drugs|December 1, 2005
NPI-2358 is a tubulin-depolymerizing agent: in-vitro evidence for activity as a tumor vascular-disrupting agentBenjamin Nicholson, G Kenneth Lloyd, Brian R Miller, et al.
International Journal of Radiation Biology|August 6, 2011
Vascular effects of plinabulin (NPI-2358) and the influence on tumour response when given alone or combined with radiationLotte B Bertelsen, Yuan Yuan Shen, Thomas Nielsen, et al.
Pageof 3